Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
group | 0.700 | None | 0.942 | 5 | 0 | 1996 | 2019 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
group | 0.700 | None | 1.000 | 3 | 0 | 1999 | 2020 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
group | 0.700 | None | 0.897 | 1 | 0 | 1994 | 2019 | ||||||||
|
ATPase plasma membrane Ca2+ transporting 1 | 0.666 | 0.500 | 1.00 |
|
group | 0.700 | None | 0.966 | 1 | 0 | 1999 | 2019 | ||||||||
|
hydroxysteroid 11-beta dehydrogenase 2 | 0.532 | 0.808 | 0.12 |
|
group | 0.700 | None | 0.964 | 1 | 0 | 1995 | 2019 | ||||||||
|
apolipoprotein A1 | 0.429 | 0.885 | 5.5E-04 |
|
group | 0.700 | None | 1.000 | 1 | 0 | 2002 | 2019 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
group | 0.700 | None | 0.824 | 1 | 0 | 1993 | 2018 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
group | 0.700 | None | 1.000 | 1 | 0 | 1998 | 2019 | ||||||||
|
endothelin converting enzyme 1 | 0.541 | 0.769 | 0.96 |
|
group | 0.630 | None | 1.000 | 2 | 0 | 2000 | 2014 | ||||||||
|
gap junction protein alpha 1 | 0.393 | 0.885 | 0.16 |
|
group | 0.610 | None | 1.000 | 2 | 0 | 2006 | 2017 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
group | 0.600 | None | 0.971 | 6 | 0 | 1979 | 2020 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
group | 0.600 | None | 0.921 | 4 | 0 | 1986 | 2020 | ||||||||
|
angiotensin II receptor type 1 | 0.423 | 0.846 | 5.3E-04 |
|
group | 0.600 | None | 0.944 | 4 | 0 | 1993 | 2020 | ||||||||
|
angiotensin II receptor type 2 | 0.496 | 0.808 | 8.2E-03 |
|
group | 0.600 | None | 1.000 | 3 | 0 | 2001 | 2019 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
group | 0.600 | None | 1.000 | 3 | 0 | 2006 | 2019 | ||||||||
|
angiotensin I converting enzyme 2 | 0.477 | 0.769 | 1.00 |
|
group | 0.600 | None | 0.982 | 2 | 0 | 2003 | 2019 | ||||||||
|
natriuretic peptide B | 0.513 | 0.808 | 9.9E-06 |
|
group | 0.600 | None | 0.955 | 2 | 0 | 1997 | 2019 | ||||||||
|
cytochrome b-245 alpha chain | 0.520 | 0.769 | 8.9E-06 |
|
group | 0.600 | None | 0.964 | 2 | 0 | 2002 | 2017 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
group | 0.600 | None | 0.964 | 2 | 0 | 1994 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
group | 0.600 | None | 1.000 | 2 | 0 | 1996 | 2020 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
group | 0.600 | None | 0.968 | 2 | 0 | 2002 | 2019 | ||||||||
|
NADPH oxidase 4 | 0.471 | 0.885 | 5.8E-20 |
|
group | 0.600 | None | 1.000 | 2 | 0 | 2007 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.600 | None | 1.000 | 2 | 0 | 1998 | 2020 | ||||||||
|
endothelin receptor type A | 0.426 | 0.885 | 0.99 |
|
group | 0.600 | None | 1.000 | 2 | 0 | 1996 | 2019 | ||||||||
|
arginine vasopressin | 0.437 | 0.846 | 7.4E-02 |
|
group | 0.600 | None | 1.000 | 2 | 0 | 1984 | 2020 |